PEDIATRIC SOLID TUMOR
Clinical trials for PEDIATRIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for PEDIATRIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail offers hope for kids with rare cancers
Disease control Recruiting nowThis study tests a combination of four drugs (cyclophosphamide, sorafenib, bevacizumab, and atezolizumab) in children and young adults with relapsed or hard-to-treat solid tumors. The goal is to find safe doses and see if the treatment shrinks tumors. The trial has two parts: fir…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 26, 2026 09:12 UTC
-
Diabetes drug shows promise in pediatric cancer fight
Disease control Recruiting nowThis early-stage study tests whether dapagliflozin, a diabetes medicine, is safe for children with brain or solid tumors that have come back or not responded to other treatments. About 20 children will receive the drug alongside standard care. The goal is to see if it can help co…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Engineered immune cells take on childhood cancers in new trial
Disease control Recruiting nowThis early-stage trial tests a personalized cell therapy for children and young adults (up to age 21) with solid tumors that have come back or not responded to standard treatment. Doctors take the patient's own immune cells, modify them to recognize a protein called B7-H3 on tumo…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New drug aims to halt Cancer's deadly spread
Disease control Recruiting nowThis early-phase trial tests a new drug called metarrestin in people with advanced solid tumors that have spread. The goal is to find a safe dose and see if it can shrink tumors or stop them from growing further. The study includes adults with pancreatic, breast, or other solid t…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Massive study aims to unlock secrets of rare cancers
Knowledge-focused Recruiting nowThis study collects biological samples and health information from up to 10,000 people with rare solid tumors or a family history of them. The goal is to learn how these tumors develop and change over time. Participants provide saliva, blood, or tumor tissue and answer yearly hea…
Matched conditions: PEDIATRIC SOLID TUMOR
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 09:09 UTC